News & Analysis on Clinical Trial Services & Contract Research And Development
Charles River Laboratories becomes the ninth contract research organisation (CRO) to open up a new pathology facility within the Chicago Technology Park (CTP), reinforcing the emerging outsourcing trend in pharmaceutical discovery and development.
UK drug discovery company, Peakdale Molecular, has introduced its collection of drug-like molecules targeted towards specific receptor families achieving drug selectivity to modulate therapeutically relevant signalling pathways.
Evotec and CHDI have formed a strategic partnership, which aims to research and develop treatments for Huntington Disease (HD), a genetic disorder that causes programmed degeneration of brain cells and loss of intellectual faculties.
Researchers have identified a protein that is thought to defend the intestinal against microbial invaders offering new insights into how the intestine fends off pathogens and potentially leading to new inflammatory bowel disease medications.